Much of the published literature regarding the novel coronavirus disease 2019 (COVID-19) constitutes lower respiratory system symptomatology, while there exists a paucity of data describing the complicated sequelae of the upper respiratory system, including chemosensory and/or sinonasal dysfunction. This study utilized the National Library of Medicine’s PubMed/MEDLINE database to query for articles describing COVID-19, SARS-CoV-2, SARS-CoV-1, MERS-CoV, and other coronaviruses, with any mention of smell, taste, or other chemosensory or sinonasal dysfunction. Aggregate analysis demonstrated an incidence of 49.6% (n = 497 of 1002; 95% CI, 46.5%-52.7%), 47.9% (n = 480 of 1002; 95% CI, 44.8%-51.0%), and 17.9% (n = 880 of 4909; 95% CI, 16.9%-19.0%) for smell loss, taste loss, and smell or taste loss, respectively, in patients infected with SARS-CoV-2. Additionally, there were significantly higher incidences of runny nose/rhinorrhea/rhinitis and nasal congestion/obstruction/blockage in other coronaviruses as compared with SARS-CoV-2 (P < .001). Understanding these less well-characterized symptoms may help develop measures for estimating early markers of disease prevalence and/or resolution. Level of evidence: 4.
MahaseE.Coronavirus COVID-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020;368:m641.
2.
WuZMcGooganJM.Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. Published online Februrary 24, 2020. doi:10.1001/jama.2020.2648
3.
SpinatoGFabbrisCPoleselJ, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. Published online April22, 2020. doi:10.1001/jama.2020.6771
4.
YanCHFarajiFPrajapatiDPBooneCEDeCondeAS.Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. Published online April12, 2020. doi:10.1002/alr.22579
5.
YanCHFarajiFPrajapatiDPOstranderBTDeCondeAS.Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol. Published online April24, 2020. doi:10.1002/alr.22592
6.
LechienJRChiesa-EstombaCMDe SiatiDR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. Published online April6, 2020. doi:10.1007/s00405-020-05965-1
7.
MaoLJinHWangM, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. Published online April10, 2020. doi:10.1001/jamaneurol.2020.1127
8.
KlopfensteinTKadiane-OussouNJTokoL, et al. Features of anosmia in COVID-19. Med Mal Infect. Published online April17, 2020. doi:10.1016/j.medmal.2020.04.006
9.
MoeinSTHashemianSMRMansourafsharBKhorram-TousiATabarsiPDotyRL.Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. Published online April17, 2020. doi:10.1002/alr.22587
10.
LovatoAde FilippisC.Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J. Published online April13, 2020. doi:10.1177/0145561320920762
11.
EliezerMHautefortCHamelAL, et al. Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. Published online April8, 2020. doi:10.1001/jamaoto.2020.0832
12.
ZouLRuanFHuangM, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177-1179.
13.
CDC COVID-19 Response Team. Characteristics of health care personnel with COVID-19—United States, February 12–April 9, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:477-481.
14.
WangRPanMZhangX, et al. Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang, Anhui, China. Int J Infect Dis. Published online April11, 2020. doi:10.1016/j.ijid.2020.03.070
15.
KimESChinBSKangCK, et al. Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: a preliminary report of the first 28 patients from the Korean cohort study on COVID-19. J Korean Med Sci. 2020;35:e142.
16.
KimballAHatfieldKMAronsM, et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:377-381.
17.
GiacomelliAPezzatiLContiF, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. Published online March26, 2020. doi:10.1093/cid/ciaa330
18.
JinXLianJSHuJH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002-1009.
19.
ToKKTsangOTLeungWS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565-574.
20.
ShiSQinMShenB, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. Published online March25, 2020. doi:10.1001/jamacardio.2020.0950
21.
GuoLRenLYangS, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. Published online March21, 2020. doi:10.1093/cid/ciaa310
22.
ZhangMQWangXHChenYL, et al. Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing [in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:215-218.
23.
WuWSLiYGWeiZF, et al. Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:489-493.
24.
ChengJLHuangCZhangGJ, et al. Epidemiological characteristics of novel coronavirus pneumonia in Henan [in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E027.
25.
WangDJuXLXieF, et al. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China [in Chinese]. Zhonghua Er Ke Za Zhi. 2020;58:E011.
26.
ShiHHanXJiangN, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20:425-434.
27.
ChanJFYuanSKokKH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514-523.
28.
WangLDuanYZhangW, et al. Epidemiologic and clinical characteristics of 26 cases of COVID-19 arising from patient-to-patient transmission in Liaocheng, China. Clin Epidemiol. 2020;12:387-391.
29.
COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: epidemiology report 6 (reporting week ending 19:00 AEDT 7 March 2020). Commun Dis Intell (2018). Published online March11, 2020. doi:10.33321/cdi.2020.44.21
30.
GuanWJNiZYHuY, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.
31.
ChenNZhouMDongX, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513.
32.
Chang LinMWeiL, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020;323(11):1092-1093.
33.
SpiteriGFieldingJDierckeM, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European region, 24 January to 21 February 2020. Euro Surveill. 2020;25(9):2000178.
34.
Beltran-CorbelliniAChico-GarciaJLMartinez-PolesJ, et al. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicenter PCR-based case-control study. Eur J Neurol. Published online April22, 2020. doi:10.1111/ene.14273
35.
ZimmermanRKRinaldoCRNowalkMP, et al. Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season. Influenza Other Respir Viruses. 2014;8:397-405.
36.
FalseyARMcElhaneyJEBeranJ, et al. Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis. 2014;209:1873-1881.
37.
LeeWJChungYSYoonHSKangCKimK.Prevalence and molecular epidemiology of human coronavirus HKU1 in patients with acute respiratory illness. J Med Virol. 2013;85:309-314.
38.
YuXLuRWangZ, et al. Etiology and clinical characterization of respiratory virus infections in adult patients attending an emergency department in Beijing. PLoS One. 2012;7:e32174.
39.
Al HajjarSAl ThawadiSAl SeraihiAAl MuhsenSImambaccusH. Human metapneumovirus and human coronavirus infection and pathogenicity in Saudi children hospitalized with acute respiratory illness. Ann Saudi Med. 2011;31:523-527.
40.
LuRJZhangLLTanWJ, et al. Characterization of human coronavirus 229E infection among patients with respiratory symptom in Beijing, Oct-Dec, 2007 [in Chinese]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009;23:367-370.
41.
SmutsHWorkmanLZarHJ.Role of human metapneumovirus, human coronavirus NL63 and human bocavirus in infants and young children with acute wheezing. J Med Virol. 2008;80:906-912.
42.
RegameyNKaiserLRoihaHL, et al. Viral etiology of acute respiratory infections with cough in infancy: a community-based birth cohort study. Pediatr Infect Dis J. 2008;27:100-105.
43.
GernaGPercivalleESarasiniA, et al. Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. J Clin Virol. 2007;38:244-250.
44.
FalseyARMcCannRMHallWJ, et al. The “common cold” in frail older persons: impact of rhinovirus and coronavirus in a senior daycare center. J Am Geriatr Soc. 1997;45:706-711.
45.
FalseyARMcCannRMHallWJ, et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc. 1995;43:30-36.
46.
IsaacsDFlowersDClarkeJRValmanHBMacNaughtonMR.Epidemiology of coronavirus respiratory infections. Arch Dis Child. 1983;58:500-503.
47.
HalimAAAlsayedBEmbarakSYaseenTDabbousS.Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients. Egypt J Chest Dis Tuberc. 2016;65:81-87.
48.
Al-AbdelyHMMidgleyCMAlkhamisAM, et al. Middle East respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia. Emerg Infect Dis. 2019;25:753-766.
49.
ChoiWSKangCIKimY, et al. Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea. Infect Chemother. 2016;48:118-126.
50.
ObohoIKTomczykSMAl-AsmariAM, et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N Engl J Med. 2015;372:846-854.
51.
ChongWCThamKYGohHKSeowE.Presentation of severe acute respiratory syndrome (SARS) patients in a screening centre. Singapore Med J. 2005;46:161-164.
52.
WangJTShengWHFangCT, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10:818-824.
53.
SuCPChiangWCMaMH, et al. Validation of a novel severe acute respiratory syndrome scoring system. Ann Emerg Med. 2004;43:34-42.
54.
ChenSYSuCPMaMH, et al. Predictive model of diagnosing probable cases of severe acute respiratory syndrome in febrile patients with exposure risk. Ann Emerg Med. 2004;43:1-5.
55.
ChenHCYoungYHLuoJP, et al. Initial otolaryngological manifestations of severe acute respiratory syndrome in Taiwan. Arch Otolaryngol Head Neck Surg. 2003;129:1157-1160.
